UBS Group AG filings document the formal disclosures of a Swiss foreign private issuer that reports annual information on Form 20-F and current information on Form 6-K. The records cover IFRS financial statements, consolidated capitalization, debt issued, additional tier 1 capital instruments, TLAC-eligible senior unsecured debt, and regulatory capital treatment under the Swiss systemically relevant bank framework.
UBS filings also describe governance and corporate-structure matters, including Articles of Association, share capital, general meeting procedures, board and executive bodies, auditor provisions, compensation votes and annual general meeting agenda items. Additional filings include Pillar 3 risk disclosures, sustainability reporting, registration-statement disclosures for securities offerings, and regulatory capital communications involving UBS Group AG and UBS AG.
UBS Group AG reported its consolidated capital-instrument and TLAC-eligible senior unsecured debt schedule as of September 30, 2026. It lists $22.792 billion of additional tier 1 capital recognized in regulatory capital, including the same total for high-trigger loss-absorbing additional tier 1 capital; total tier 2 capital was $0, and $90.8 billion of TLAC-eligible senior unsecured debt was eligible for the gone-concern requirement. These are separate regulatory categories, not a combined total.
The instrument-level tables list outstanding amounts, currencies, maturities and first optional call dates. The gone-concern amounts exclude the add-back of 45% of qualifying unrealized gains on financial assets measured at fair value through other comprehensive income. UBS also states that the nominal amount outstanding for one instrument was reduced from its issue-date amount as a result of a tender offer on September 2, 2026.
UBS Group AG reported total capitalization of $413,871 million as of September 30, 2026, compared with $432,981 million as of June 30, 2026. At September 30, 2026, capitalization included $324,981 million of debt issued, $88,613 million of equity attributable to shareholders and $277 million of equity attributable to non-controlling interests.
UBS Group, as an institutional investment manager, filed a Form 13F combination report, indicating that part of its reportable U.S. equity holdings are included here and part are reported by other managers. The filing covers 23,043 reportable positions with an aggregate reported value of $786,018,117,990 (rounded to the nearest dollar). The report lists 10 other included managers, such as UBS Financial Services Inc. and UBS AG, reflecting the scale and complexity of UBS’s asset management structure for U.S.-listed securities.
UBS Group AG provides a detailed overview of capital instruments and other obligations contributing to its total loss-absorbing capacity under the Swiss systemically relevant bank framework as of 30 June 2026. High-trigger loss-absorbing Additional Tier 1 capital totaled 23,513 (USD m), and TLAC-eligible senior unsecured debt totaled 97,651 (USD m).
The tables list each instrument’s currency, outstanding amount, regulatory capital recognition and gone concern eligibility, reflecting rules such as instruments remaining eligible for gone concern capital until one year before maturity. UBS announced it intends to redeem a 750 (USD m) Additional Tier 1 instrument on 29 July 2026, which therefore no longer counts as high-trigger capital. Obligations under outstanding Credit Suisse Group AG debt securities have become obligations of UBS Group AG.
UBS Group filed a Form 13F combination report summarizing its institutional holdings. The filing lists 22,771 Form 13F information table entries with a reported aggregate market value of $666,317,424,467. The report identifies 11 other included managers and is signed by Andrew Johnson on 05-05-2026.
UBS Group AG has filed a Form 6‑K to provide its newly registered Articles of Association, setting out its current capital structure and governance rules. The share capital is USD 327,780,516.40, divided into 3,277,805,164 registered shares with a par value of USD 0.10 each.
The Articles authorize conditional capital for employee equity plans and convertible instruments, as well as up to 700,000,000 shares of conversion capital for contingent Financial Market Instruments. They also codify the powers of the General Meeting, Board of Directors and Group Executive Board, and detail the framework for approving and paying compensation.
UBS Group AG filed a Form 6-K providing a snapshot of its capitalization in US dollars under IFRS Accounting Standards as of 31 March 2026 and incorporating this information into existing registration statements.
As of 31 March 2026, UBS Group reported short-term debt issued of USD 97,642m and long-term debt issued of USD 246,279m, for total debt issued of USD 343,922m. Of the long-term debt, USD 21,133m was eligible as high-trigger loss-absorbing additional tier 1 capital instruments, and 88% of total debt was unsecured. Equity attributable to shareholders was USD 92,247m and equity attributable to non-controlling interests was USD 255m, resulting in total capitalization of USD 436,424m, compared with USD 418,984m as of 31 December 2025.
UBS Group AG provides detailed information on its capital instruments and total loss-absorbing capacity as of 31 March 2026. The group reports high-trigger loss-absorbing additional tier 1 capital of USD 23,649m and TLAC-eligible senior unsecured debt of USD 100,583m under the Swiss systemically relevant bank framework.
The tables list each instrument’s issuer, ISIN, currency, outstanding amount, amount recognized in regulatory capital, gone concern eligibility, maturity and first call dates. Footnotes explain treatment of legacy Credit Suisse instruments, amortized face values and adjustments for own-credit-related gains or losses.
UBS Group outlines major potential effects from new Swiss capital rules and proposed changes to the treatment of foreign subsidiaries. Changes to the Capital Adequacy Ordinance will shorten the capital life of software to three years and increase prudential valuation deductions, which UBS estimates will eliminate about USD 4bn of net CET1 capital at Group level and lower its CET1 ratio by roughly 0.8 percentage points.
Separately, a proposal to fully deduct foreign participations from UBS AG’s CET1, phased in over seven years, would require about USD 20bn of additional CET1. Together with around USD 15bn of previously communicated incremental capital linked to the Credit Suisse acquisition, UBS calculates total extra CET1 needs of about USD 37bn, with an annual capital cost of around USD 3bn. UBS describes the package as extreme, warns of economic consequences for Switzerland, but maintains its 2026 targets for an underlying return on CET1 capital of around 15% and a cost/income ratio below 70%, and says it remains committed to planned 2026 capital returns.
UBS Group AG has published the agenda for its 2026 Annual General Meeting, to be held on 15 April 2026 in Basel. The Board proposes an ordinary cash dividend of USD 1.10 per share for the 2025 financial year.
Shareholders will vote on approval of the 2025 financial statements, advisory votes on the 2025 Compensation and Sustainability Reports, compensation budgets for directors and executives, and the discharge of the Board of Directors and Group Executive Board. Most directors, including Chairman Colm Kelleher, are standing for re-election, while Lukas Gähwiler, William C. Dudley and Jeanette Wong will not.
New nominees to the Board are Markus Ronner, Agustín Carstens and Luca Maestri. The agenda also includes re-election of the independent proxy and auditors and an ordinary reduction of share capital through cancellation of shares repurchased under the 2024 share repurchase program.